Author

Francesca Sarno

Spanish National Cancer Research CentreORCID 0000-0003-0100-8568Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Francesca Sarno1 paper

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Alba De MartinoiD· 1 shared Álvaro OteroiD· 1 shared Antonio CubilloiD· 1 shared Carmen Blanco‐AparicioiD· 1 shared Daniel LiethaiD· 1 shared Elena GarraldaiD· 1 shared Estela VegaiD· 1 shared Jorge Luis Martinez-TorrecuadradaiD· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alba De MartinoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsbioRxivPreprintAug 28, 2017

Whole-exome sequencing of plasma cell-free DNA portrays the somatic mutation landscape of refractory metastatic colorectal cancer and enables the discovery of mutated KDR/VEGFR2 receptors as modulators of anti-angiogenic therapies.

Rodrigo Almeida Toledo, Elena Garralda, Maria Mitsi…·Manuel M. Hidalgo

This study uses whole-exome sequencing of plasma cell-free DNA to analyze somatic mutations in metastatic colorectal cancer and identifies KDR/VEGFR2 mutations affecting anti-angiogenic therapy response.

DOI 10.1101/177287

humanwhole-exome sequencing

𝕏 PostBluesky